Scarica l'app Stockscreener
3.75
18.30%
0.58
Dopo l'orario di chiusura:
3.75
Replimune Group Inc Borsa (REPL) Ultime notizie
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm - The Malaysian Reserve
Shareholders who lost money on Replimune Group, Inc. - GlobeNewswire
Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - GlobeNewswire Inc.
Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma DrugHagens Berman - TradingView
Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) InvestorsLead Plaintiff Deadline on September 22, 2025 - ACCESS Newswire
Replimune Group (REPL.O) Sees Sharp Intraday Surge — But Why? - AInvest
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Morningstar
Combining machine learning predictions for Replimune Group Inc.AI Entry Timing Prediction for Swing Traders - Newser
Market reaction to Replimune Group Inc.’s recent newsFree Stock Market Watch With Alerts - Newser
How to track smart money flows in Replimune Group Inc.Trend Reversal Probability Forecast Update - Newser
Investors in Replimune Group, Inc. (REPL) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire
Replimune’s SWOT analysis: biotech stock faces FDA setback, industry remains positive - Investing.com
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
Replimune (REPL) Faces Securities Class Action Following - GlobeNewswire
REPL LAWSUIT: Replimune Group, Inc. Sued for Fraud after - GlobeNewswire
REPL LAWSUIT NOTICE: Replimune Group, Inc. Investors are Notified of the Pending Securities Fraud Class ActionContact BFA Law before the September 22 Deadline - ACCESS Newswire
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL - FinancialContent
Replimune Group, Inc. (REPL) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
Important Notice to Long-Term Shareholders of Alto - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
REPL Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Replimune Group, Inc. - GlobeNewswire
How to escape a deep drawdown in Replimune Group Inc.Free Growth Based Investment Plan Guidance - Newser
Using portfolio simulators with Replimune Group Inc. includedFree Buy Low Sell High Stock Watch - Newser
Order flow analysis tools used on Replimune Group Inc. Buy/Sell Zone Confirmation Technical Analysis - Newser
Securities Litigation in Biotech: Navigating the Replimune Crisis and Its Broader Implications - AInvest
Regulatory Setbacks and Legal Risks: Replimune Group's Turbulent Path in the Biotech Sector - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc.REPL - WV News
Leerink Partnrs Expects Lower Earnings for Replimune Group - Defense World
REPL CLASS ACTION ALERT: FDA Response Letter Leads to - GlobeNewswire
Replimune Group (NASDAQ:REPL) Cut to “Underperform” at BMO Capital Markets - Defense World
Replimune Group (NASDAQ:REPL) Cut to “Equal Weight” at Barclays - Defense World
Replimune Group (NASDAQ:REPL) Cut to “Neutral” at HC Wainwright - Defense World
REPLIMUNE GROUP, INC. (NASDAQ: REPL) INVESTOR ALERT Investors With Large Losses in Replimune Group, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - ACCESS Newswire
[REPL] ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Replimune Group, Inc. Investors - TradingView
Potential Securities Fraud: Levi & Korsinsky Investigates Replimune Group, Inc. (REPL) - ACCESS Newswire
Replimune Group, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Lost Money on Replimune Group, Inc. (REPL)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Is Replimune Group Inc. a good long term investmentTremendous wealth creation - PrintWeekIndia
ROSEN, LEADING INVESTOR COUNSEL, Encourages Replimune - GlobeNewswire
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Ongoing Replimune Group, Inc. (REPL) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire
Faruqi & Faruqi Reminds Replimune Investors of the Pending - GlobeNewswire
REPL LEGAL UPDATE: Replimune Group, Inc. Sued after FDA Response Letter -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline - FinancialContent
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 – REPL - Morningstar
REPL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Replimune Group (NASDAQ:REPL) Cut to “Hold” at Leerink Partnrs - Defense World
Replimune Group (NASDAQ:REPL) Cut to Hold at Cantor Fitzgerald - Defense World
Shareholder Alert: Robbins LLP Informs Investors of The Replimune Group, Inc. Class Action - ACCESS Newswire
Replimune Group and the Biotech Litigation Time Bomb: Evaluating Risks in a High-Stakes Sector - AInvest
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Replimune Group, Inc. Investors – REPL - Business Wire
Shareholders Alert: Investigation Into Replimune Group, Inc. (REPL)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
INVESTOR ALERT: Investigation of Replimune Group, Inc. (REPL) Announced by Holzer & Holzer, LLC - GlobeNewswire
REPL STOCK NEWS: Replimune Group, Inc. (NASDAQ:REPL) is - GlobeNewswire
REPL ACTIVE INVESTIGATION: Lost Money on Replimune Group, Inc.? Contact Levi & Korsinsky Now - ACCESS Newswire
10.28%
2.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):